Status:
RECRUITING
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Preeclampsia
HELLP Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interfere...
Eligibility Criteria
Inclusion
- older than 18 yrs
- diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy
Exclusion
- unable for informed consent
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07151339
Start Date
November 1 2024
End Date
November 1 2030
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Schleswig- Holstein
Kiel, Germany, 24105